| King David PDirector · 274 transactions | — | 332.1K†as of May 2020 | 2.12M | — | 1.35M |
| Schechter Adam HPresident & CEO, Director · 62 transactions | — | 107.2K | 269.4K | — | 50.9K |
| Novak Richard LEVP, Strategic Planning · 103 transactions | — | 64.4Kas of Mar 2006 | 280.8K | — | 286.4K |
| Haas WilliamEVP, Esoterix Business · 21 transactions | — | 62.3Kas of Mar 2008 | 99.6K | — | 46.6K |
| Herring Joseph LCEO of Covance Drug Division · 4 transactions | — | 61.4K†as of Jul 2015 | 20.0K | — | 36.9K |
| Eisenberg Glenn AExecutive Vice President · 141 transactions | — | 41.5Kas of Mar 2025 | 317.0K | — | 168.5K |
| Conrad Andrew JEVP, Chief Scientific Officer · 7 transactions | — | 38.7K†as of Feb 2011 | 8.1K | 6.1K | 10.0K |
| Caveney Brian JEVP, Pres of ED, CMO & CSO · 80 transactions | — | 36.5K | 65.1K | 86.35 | 3.5K |
| Mac Mahon Thomas PDirector · 680 transactions | — | 32.3Kas of Sep 2012 | 1.83M | — | 1.92M |
| Eberts F Samuel IIIChief Legal Officer, Secretary · 91 transactions | — | 28.8Kas of Feb 2019 | 120.3K | — | 88.4K |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics · 90 transactions | — | 28.4Kas of Mar 2016 | 314.5K | — | 240.1K |
| Lai Goldman MylaEVP & Chief Medical Officer · 318 transactions | — | 25.0K†as of Nov 2008 | 268.2K | — | 242.3K |
| Belingard Jean LucDirector · 37 transactions | — | 22.6Kas of May 2008 | 3.1K | — | — |
| Walton Andrew ScottEVP · 40 transactions | — | 22.3Kas of Apr 2012 | 55.6K | — | 20.1K |
| Berberian LanceEVP, Special Advisor, Strategy · 102 transactions | — | 20.0Kas of Mar 2025 | 74.2K | — | 27.1K |
| Hardison Don MEVP · 9 transactions | — | 19.9Kas of Dec 2009 | 29.6K | — | 2.3K |
| Miller Benjamin REVP, Sales & Marketing · 52 transactions | — | 19.9Kas of Mar 2008 | 76.4K | — | 47.0K |
| Keller Deborah LCEO, Covance Drug Development · 4 transactions | — | 19.8Kas of Mar 2016 | 12.9K | — | — |
| Hayes William BChief Financial Officer, EVP · 135 transactions | — | 19.4Kas of Jun 2014 | 580.9K | — | 508.9K |
| Lane Wendy EDirector · 78 transactions | — | 19.4K†as of May 2014 | 23.7K | 400 | 14.3K |
| Smith Bradford TDirector · 469 transactions | — | 18.2Kas of Feb 2009 | 389.7K | — | 378.3K |
| Ratliff John DCEO, Covance Drug Development · 14 transactions | — | 18.1K†as of Apr 2019 | 25.9K | — | — |
| Belingard Jean-LucDirector · 70 transactions | — | 17.8Kas of Feb 2024 | 45.8K | — | 48.5K |
| Schroeder Mark SEVP, Pres Diagnostics & COO · 95 transactions | — | 15.8K | 69.9K | — | 31.9K |
| Mittelstaedt Robert E JrDirector · 76 transactions | — | 15.5Kas of May 2019 | 40.8K | — | 34.7K |
| Weikel M KeithDirector · 44 transactions | — | 14.0Kas of May 2014 | 13.2K | — | 4.0K |
| Neupert Peter MDirector · 17 transactions | — | 13.8K | 15.3K | 3.5K | — |
| Kong GarhengDirector · 13 transactions | — | 13.7K | 13.7K | — | — |
| Dodson Edward TPrincipal Accounting Officer · 44 transactions | — | 13.7Kas of Apr 2019 | 43.3K | — | 25.3K |
| Kirchgraber Paul RCEO, Covance Drug Development · 48 transactions | — | 12.9Kas of May 2023 | 36.2K | — | 16.3K |
| Cook Woodrow LEVP, Eastern Operations · 29 transactions | — | 12.7Kas of Oct 2007 | 54.0K | — | 49.2K |
| Troub Allen WEVP, Western Operations · 3 transactions | — | 12.7Kas of Mar 2007 | 6.0K | — | — |
| Rubenstein Arthur HDirector · 37 transactions | — | 11.8Kas of May 2014 | 9.2K | — | — |
| Wallace Andrew GDirector · 56 transactions | — | 11.7Kas of May 2007 | 8.8K | — | 9.8K |
| Anderson Kerrii BDirector · 77 transactions | — | 9.9K† | 39.6K | — | 31.7K |
| Fonseca LidiaChief Information Officer · 27 transactions | — | 9.1Kas of Mar 2013 | 33.0K | — | 20.2K |
| Williams R SandersDirector · 72 transactions | — | 8.1Kas of Feb 2024 | 34.9K | — | 23.8K |
| Summy Amy B.EVP, Chief Marketing Officer · 47 transactions | — | 7.9K | 23.9K | — | 8.6K |
| Vaughn Bryan TEVP, Diagnostics · 8 transactions | — | 6.7K | 2.3K | — | — |
| Gilliland Dwight GaryDirector · 23 transactions | — | 6.7Kas of Jul 2025 | 12.4K | — | 5.7K |
| DiVincenzo Jonathan P.EVP, Pres, Central Labs & Intl · 13 transactions | — | 6.4Kas of Mar 2024 | 3.9K | — | 500 |
| van der Vaart Sandra DEVP, Corporate Affairs · 94 transactions | — | 6.2K | 54.8K | — | 34.7K |
| Brecher Mark ECMO, LabCorp Diagnostics · 48 transactions | — | 5.5Kas of Mar 2015 | 73.9K | — | 62.3K |
| Davis Jeffrey A.Director · 7 transactions | — | 5.5K | 5.5K | — | — |
| Seltz Judith CEVP, CHRO · 16 transactions | — | 5.3Kas of Mar 2023 | 4.9K | 580 | — |
| Bailey Megan D.EVP, Pres, Central Labs & Intl · 28 transactions | — | 5.3K | 7.7K | — | — |
| Graham Anita ZEVP, CHRO · 14 transactions | — | 5.2K | 8.7K | — | — |
| Oyegunwa AkinboladeEVP, CIO & CTO · 18 transactions | — | 5.1K | 3.4K | — | — |
| Uthgenannt Lisa JChief Human Resources Officer · 33 transactions | — | 4.7Kas of Sep 2019 | 36.0K | — | 20.9K |
| Wengel Kathryn EDirector · 5 transactions | — | 4.1K | 4.1K | — | — |
| Kyle Kathryn WEVP, Chief Legal Officer · 9 transactions | — | 3.8K | 2.2K | — | 762 |
| Meltzer Jonathan CEVP, Operations · 12 transactions | — | 3.6K | 3.2K | — | 1.1K |
| Parham Richelle PDirector · 11 transactions | — | 3.4K | 10.4K | — | 7.0K |
| Kliphouse Kirsten MarieDirector · 4 transactions | — | 3.2K | 3.2K | — | — |
| Coles N AnthonyDirector · 4 transactions | — | 2.6Kas of Feb 2013 | 2.8K | — | — |
| Rothman PaulDirector · 3 transactions | — | 2.6K | 2.6K | — | — |
| Wilkinson Peter JSVP, Chief Accounting Officer · 78 transactions | — | 1.9K | 21.0K | — | 13.8K |
| Gary M. HuffCEO, LabCorp Diagnostics · 11 transactions | — | 1.8Kas of Sep 2018 | 4.9K | — | 1.6K |
| Wang Julia AijunChief Financial Officer, EVP · 6 transactions | — | 1.8K | 2.6K | — | — |